Long-term survival after intensive care unit admission with sepsis

Sasse, Kent C.; Nauenberg, Eric; Long, Alan; Anton, Bette; Tucker, Harvey J.; Hu, Teh-wei

doi:10.1097/00003246-199506000-00008

Cited by 142 publications

(79 citation statements)

References 48 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…95,[102][103][104] Two further studies were also identified in the hand search of relevant journals 74,105 and three studies [106][107][108] were identified from the reference lists of the included studies. The flow chart of studies included in the review is reported in Figure 38.…”

Section: Studies Included In the Systematic Reviewmentioning

confidence: 99%

“…The flow chart of studies included in the review is reported in Figure 38. Ten individual publications 74,93,95,102,103,[105][106][107][108][109] were identified from nine separate studies (with two publications coming from the same study).…”

Section: Studies Included In the Systematic Reviewmentioning

confidence: 99%

“…Generally, the study populations included more males than females and the mean age of the cohorts ranged from 57 years to 63 years. Most of the studies measured severity of illness by using the APACHE II score 74,95,102,103,[107][108][109] and the mean score varied between 20.9 and 24.8 across the studies. Only limited information was reported on the proportion of patients with multiple organ dysfunction.…”

Section: Overview Of Included Studiesmentioning

confidence: 99%

See 2 more Smart Citations

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

Soares

Welton²,

Harrison³

et al. 2012

Health Technol Assess

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects...

show abstract

Section: Studies Included In the Systematic Reviewmentioning

confidence: 99%

Section: Studies Included In the Systematic Reviewmentioning

confidence: 99%

Section: Overview Of Included Studiesmentioning

confidence: 99%

See 1 more Smart Citation

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

Soares

Welton²,

Harrison³

et al. 2012

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…The morbidity in ICU for septic patients is 10% [29], while the fatality rate of SAE is as high as 51.0-72.0% [30]. However, SAE as one of the rare cause of initial central AVS has not been reported.…”

Section: Discussionmentioning

confidence: 99%

Initial Presenting as Acute Vertigo Syndrome in Sepsis Associated Encephalopathy: A Retrospective Case Series

Tong¹

2017

SOJN

View full text Add to dashboard Cite

Objective: To investigate whether sepsis associated encephalopathy (SAE) is a cause of acute vertigo syndrome (AVS). Methods:From Jen 2014 to Des 2016 period, the clinical data in 7 patients who were from a hospital intensive care unit (ICU), because of misdiagnosed SAE whose complaint was vertigo or dizziness, was retrospectively analyzed.Results: Among 7 misdiagnosed SAE patients, 5 were male and 2 were female, with a median age of 60 years (range, 23-82 years). All patients presented with AVS at onset. Of them, transient or recurrent AVS occurred in 6 patients, and persistent AVS in 1case. 3 patients by brain angiography showed the ischemic lesions in the central vestibular partway, however, all of 7 cases with AVS presented a central vestibular impaired mechanism from septic shock or sepsis, supporting AVS was a central AVS. The patient 1 only presented isolated central AVS and with no others brain dysfunction, so met the diagnosis of mild SAE, and with a favorable prognosis. The other 6 cases developed from mild brain dysfunction (central AVS) to deep coma and multiple organ failure, met the diagnosis of severe SAE with multiple organ failure, and all of them died eventually.Conclusions: SAE might be a little-known cause of the central AVS. A recognition of this issue facilitate earlier identification and more timely treatment in patients with AVS with SAE.

show abstract

“…The rate of occurrence is high, with over 1665 cases of sepsis occurring yearly in the United States, reaching a lethality rate of 20-50 percent [8]. It is also important to note that, even with ideal treatment, the possibility of death is approximately 40 percent and can be greater than 50 percent in the most severe cases [9][10][11][12].…”

Section: Properties Of the Cytokinesmentioning

confidence: 99%

Anti-Inflammatory Cytokines in Sepsis: Immunological Studies and In Silico Investigation

AP¹,

DLS²,

PSB³

et al. 2016

J Pharma Care Health Sys

View full text Add to dashboard Cite

The pathophysiology, diagnosis, treatment and prognosis of sepsis remain major challenges for contemporary clinical practice. In this sense, efforts to broaden the knowledge about the mechanisms involved in systemic inflammation and to identify new methods for detecting sepsis in the early stages and the stratification of patients are extremely important. The purpose of this paper is to review the role of the anti-inflammatory cytokines in sepsis and present perspectives on the in silico investigation of the role of these mediators in this nosological entity, using the computational system AutoSimmune.

show abstract

Long-term survival after intensive care unit admission with sepsis

Cited by 142 publications

References 48 publications

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

Initial Presenting as Acute Vertigo Syndrome in Sepsis Associated Encephalopathy: A Retrospective Case Series

Anti-Inflammatory Cytokines in Sepsis: Immunological Studies and In Silico Investigation

Contact Info

Product

Resources

About